Your Good Partner in Biology Research

  1. Home
  2. 抗体
  3. 多克隆抗体
  4. HSD17B1 Antibody

HSD17B1 Antibody

  • 货号：
    CSB-PA010766LA01HU
  • 规格：
    ￥440
  • 促销：
    小规格抗体限时一口价
  • 图片：
    • IHC image of CSB-PA010766LA01HU diluted at 1:100 and staining in paraffin-embedded human prostate cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
    • IHC image of CSB-PA010766LA01HU diluted at 1:100 and staining in paraffin-embedded human colon cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
    • Immunofluorescence staining of Hela cells with CSB-PA010766LA01HU at 1:33, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
  • 其他：

产品详情

  • 产品名称：
    Rabbit anti-Homo sapiens (Human) HSD17B1 Polyclonal antibody
  • Uniprot No.：
    P14061
  • 基因名：
    HSD17B1
  • 别名：
    17 beta HSD 1 antibody; 17 beta hydroxysteroid dehydrogenase type 1 antibody; 17-beta-HSD 1 antibody; 17-beta-hydroxysteroid dehydrogenase type 1 antibody; 20 alpha-hydroxysteroid dehydrogenase antibody; 20-alpha-HSD antibody; DHB1_HUMAN antibody; E17KSR antibody; E2DH antibody; EDH17B1 antibody; EDH17B2 antibody; EDHB17 antibody; Estradiol 17 beta dehydrogenase 1 antibody; Estradiol 17-beta-dehydrogenase 1 antibody; HSD17 antibody; HSD17B1 antibody; Hydroxysteroid (17 beta) dehydrogenase 1 antibody; MGC13814 antibody; Placental 17 beta hydroxysteroid dehydrogenase antibody; Placental 17-beta-hydroxysteroid dehydrogenase antibody; SDR28C1 antibody; Short chain dehydrogenase/reductase family 28CE,member 1 antibody
  • 宿主：
    Rabbit
  • 反应种属：
    Human
  • 免疫原：
    Recombinant Human Estradiol 17-beta-dehydrogenase 1 protein (268-328AA)
  • 免疫原种属：
    Homo sapiens (Human)
  • 标记方式：
    Non-conjugated

    本页面中的产品，HSD17B1 Antibody (CSB-PA010766LA01HU)，的标记方式是Non-conjugated。对于HSD17B1 Antibody，我们还提供其他标记。见下表：

    可提供标记
    标记方式 货号 产品名称 应用
    HRP CSB-PA010766LB01HU HSD17B1 Antibody, HRP conjugated ELISA
    FITC CSB-PA010766LC01HU HSD17B1 Antibody, FITC conjugated
    Biotin CSB-PA010766LD01HU HSD17B1 Antibody, Biotin conjugated ELISA
  • 克隆类型：
    Polyclonal
  • 抗体亚型：
    IgG
  • 纯化方式：
    >95%, Protein G purified
  • 浓度：
    It differs from different batches. Please contact us to confirm it.
  • 保存缓冲液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
  • 产品提供形式：
    Liquid
  • 应用范围：
    ELISA, IHC, IF
  • 推荐稀释比：
    Application Recommended Dilution
    IHC 1:20-1:200
    IF 1:20-1:200
  • Protocols：
  • 储存条件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 货期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

产品评价

靶点详情

  • 功能：
    Favors the reduction of estrogens and androgens. Converts estrone (E1) to a more potent estrogen, 17beta-estradiol (E2). Also has 20-alpha-HSD activity. Uses preferentially NADH.
  • 基因功能参考文献：
    1. Our genetic study demonstrated HSD17B1 937 G variant as a risk factor for infertility in women with stage I and II endometriosis in Polish Caucasian patients. PMID: 28405865
    2. HSD17B1 is a promising marker to predict EC prognosis. PMID: 27923582
    3. Macronutrient intakes were associated with serum estradiol level, and these associations may be modified by HSD17B1 polymorphism in postmenopausal Japanese women. PMID: 28980890
    4. the effect of 17beta-HSD1 expression on breast cancer cell transcript profile in steroid-deprived condition, was investigated. PMID: 27544780
    5. Mutation in the 17-beta-hydroxysteroid dehydrogenase gene is associated with congenital adrenal hyperplasia. PMID: 28207417
    6. Substrate inhibition of 17beta-HSD1 in tumor epithelial cells and regulation of 17beta-HSD7 by 17beta-HSD1 knockdown has been demonstrated. PMID: 28554725
    7. 10 natural products were evaluated leading to inhibition of the activity of 17beta-HSD1 at the concentration of 25 muM, and six of them inhibit the activity over 50%. PMID: 27933483
    8. The structure of human 17beta-HSD1 and biological function have been studied extensively in the last two decades. In humans, the enzyme is expressed in placenta, ovary, endometrium and breast; high activity of estrogen activation provides the basis of 17beta-HSD1's implication in estrogen-dependent diseases, such as breast cancer, endometriosis and non-small cell lung carcinomas. [Review] PMID: 27102893
    9. These findings suggested that the HSD17B1 Ser312Gly polymorphism might confer genetic cancer susceptibility in an ethnic-dependent manner, especially among Caucasians. PMID: 26923943
    10. The rs605059 polymorphism of the HSD17B1 gene is associated with increased risk of recurrent spontaneous abortion. PMID: 25394609
    11. Review/Meta-analysis: HSD17B1 rs605059 polymorphisms were not associated with the risks of endometrial cancer or endometriosis. PMID: 26261478
    12. the HSD17B1 transcript and protein were identified in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. PMID: 26054693
    13. Increased expression of HSD17B1 in NSCLC may contribute to an elevated intratissue level of E2 and consequently may support the development and spread of cancer. PMID: 25564397
    14. The key enzymes of ovarian steroidogenesis, CYP 19 and 17beta-HSD, are active in the ovaries of postmenopausal women. PMID: 24855493
    15. 17beta-HSD1 and 17beta-HSD7 are principal reductive 17beta-hydroxysteroid dehydrogenases and major players in the viability of estrogen-dependent breast cancer cells. PMID: 25257817
    16. E1-induced ERELuc activity in the inhibitor-treated uterus was reduced by the HSD17B1 inhibitor. PMID: 25617485
    17. Single nucleotide polymorphism in HSD17B1 gene is associated with hepatocellular carcinoma. PMID: 24563232
    18. Onset of epileptiform discharges is modestly delayed in slices from ovariectomized rats replaced with physiologically relevant doses of EB, but the number of discharges is not affected. PMID: 24113171
    19. results demonstrated that HSD17B1 expression and its ability to convert the weak estrogen E1 to the more potent E2 can be associated with DNA methylation in the 5' flanking region in GC cells. PMID: 23916544
    20. analysis of intratumoral localization and activity of 17beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer PMID: 23837683
    21. We found the presence of HSD17B1 transcripts and proteins in human Jurkat acute T cell leukemia, Hut-78 and Raji B lymphoma cells PMID: 23540283
    22. HSD17B1-mediated decreased conversion of estrone to estradiol may reduce the estrogenic effects, thereby reducing the risk of developing breast cancer during long-term hormone replacement therapy use. [Meta-analysis] PMID: 23430226
    23. study demonstrated that 17beta-HSD1 increases breast cancer cell migration, in spite of its positive regulation of the antimetastatic gene NM23 PMID: 22691413
    24. In this review, the results suggest that HSD17B1 and PR polymorphism may play a role in the risk of endometriosis PMID: 22613790
    25. Frequencies of rs605059 AA genotype and A allele were significantly increased in Chinese patients with uterine leiomyoma compared to healthy controls. PMID: 22546946
    26. Data suggest that HSD17B1 is overexpressed in endometrial cancer tissue; HSD17B1 appears responsible for shift toward reductive metabolism (i.e., greater reduction of estrone to 17-beta-estradiol; lesser oxidation of 17-beta-estradiol to estrone). PMID: 22362820
    27. Breast cancer cells T47D, MCF-7, BT 20, and JEG 3 as control cells, were chosen to evaluate the contribution of 17beta-hydroxysteroid dehydrogenase type 1 and type 2 to the estradiol/estrone ratio. PMID: 22253796
    28. reduced HSD17B1 expression can be associated with DNA methylation in the 5' flanking region of HSD17B1 in CRC from the proximal colon. PMID: 22176788
    29. HSD17B1 gene may contribute to sex steroid-mediated effects on colorectal cancer development. PMID: 21317201
    30. SNPs (HSD17B1 (rs2010750, rs598126 and rs676387), COMT (rs4680), UGT1A1 (rs8175347) and ESR1 (rs9340799)) seem to be related to mammographic density in the same direction of their associations with breast cancer risk PMID: 22199302
    31. Data show that in 17beta-HSD1 inhibitors are placed in the substrate-binding site and they occupy an apolar subpocket consisting of the following amino acids: Gly94, Leu95, Leu96, Asn152, Tyr155, and Phe192. PMID: 21857977
    32. HSD17B1 upregulation by sodium butyrate is associated with increased conversion of E1 to E2 in colorectal cancer cells. PMID: 21563966
    33. Obese women with selected CYP19 and 17-beta HSD gene variants had remarkably different E2 trajectories around the the final menstrual period, resulting in different postmenopausal E2 levels. PMID: 21198743
    34. Genetic variants in ESR1, ESR2, and HSD17B1 genes could modify susceptibility to endometriosis and might influence the fertility status in endometriosis patients. PMID: 20586553
    35. This study suggests that HSD17B1 312Gly allele may be a protective factor for breast cancer development in Caucasians. PMID: 20151320
    36. CYP17 (T1931C) and HSD17beta1 (A1954G) polymorphisms may jointly increase the risk of breast cancer. PMID: 20193327
    37. genetic assiciation studies [Japan, Brazil]: data suggest SNP in 17beta-HSD1 gene may modify association between dietary isoflavone intake & breast cancer PMID: 20432167
    38. 17beta-HSD1 up-regulates breast cancer cell growth by a dual action on estradiol synthesis and dihydrotestosterone inactivation. PMID: 20172961
    39. A significant increment of 17beta-HSD1 followed exemestane neoadjuvant therapy of postmenopausal ER-positive breast carcinoma. This may represent the compensatory response of breast carcinoma tissues to estrogen depletion. PMID: 20151319
    40. An amino acid important for steroid/retinoid discrimination was identified and its significance was highlighted by the results of molecular modeling studies. PMID: 20382160
    41. Data report structures of the binary and ternary complexes of 17beta-HSD1 with a new inhibitor E2B, opening a new orientation of breast cancer treatment. PMID: 19929851
    42. increased activity in hypothalamic obesity PMID: 12519880
    43. possible hypothalamic mediators regulating adipose tissue 11 beta-HSD-1 might include down-regulation by CRH, ACTH, and alpha 2 sympathetic stimulation, and up-regulation by beta 2 sympathetic stimulation and by the cytokines TNFalpha and IL-1 beta PMID: 12519881
    44. examination of amplification in breast cancer PMID: 12527905
    45. Evidence for association between the Ser312Gly polymorphism in HSD17B1 and endometriosis was found in a Japanese population PMID: 15640252
    46. the germline variants in HSD17B1 characterized by htSNPs do not substantially influence the risk of prostate cancer in U.S. and European whites PMID: 16311626
    47. Corticotrophin-releasing hormone (CRH) increased whereas alpha-helical CRH decreased the mRNA levels of STS, CYP19A1, and HSD17B1, the key enzymes for estrogen synthesis. PMID: 16467490
    48. HSD17B1 is a multispecific enzyme. PMID: 16480815
    49. importance of 17HSD type 2 in breast cancer- & non-tumour breast cell lines; high or low expression affected oestradiol concentration significantly; response dependent on endogenous expression of 17HSD type 1 which seems to be dominant to 17HSD type 2 PMID: 16954436
    50. These results suggest that soy consumption may interact with polymorphisms in the 17beta-HSD1 gene in relation to endometrial cancer risk. PMID: 17301695

    显示更多

    收起更多

  • 亚细胞定位：
    Cytoplasm.
  • 蛋白家族：
    Short-chain dehydrogenases/reductases (SDR) family
  • 数据库链接：

    HGNC: 5210

    OMIM: 109684

    KEGG: hsa:3292

    STRING: 9606.ENSP00000466799

    UniGene: Hs.654385